Caring Brands (CABR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 4, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the S-1 for Q2 FY2026, filed Oct 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CABR SEC filings page.
Caring Brands, Inc. (CABR) reported $4K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025's tiny sales base could not support its cost structure, leaving financing inflows central to funding reported cash needs.
The net loss widened from$1.5M in FY2024 to$6.3M in FY2025, while operating cash flow was-$1.7M ; this earnings-to-cash gap indicates that reported losses included substantial non-cash or timing effects. The combination of shrinking assets and a financing cash inflow suggests the balance sheet was being reshaped while operations remained cash-consuming.
Revenue of
Assets fell
Financial Health Signals
We do not publish a peer-relative financial health score for Caring Brands, Inc., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Caring Brands, Inc. scores 12.40, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $9.4M against total liabilities of $235K. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Caring Brands, Inc. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass.
Caring Brands, Inc. reported a net loss of $6.3M while operations used $1.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Caring Brands, Inc. reported an operating loss of $5.9M against $19K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Caring Brands, Inc. reported a net loss of $639K in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Caring Brands, Inc. earned -$0.10 per diluted share (EPS) in Q2 2026. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Caring Brands, Inc. held $1.8M in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
Caring Brands, Inc. repurchased no shares in Q2 2026. Against the prior quarter it is down 100.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
CABR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'26S-1 | Q1'26S-1 | Q4'25S-1 | Q3'2510-Q | Q2'25S-1 | Q1'2510-Q | Q4'24S-1 | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | $419-9.9% | $740 | $2K | $1K | $465 | N/A |
| Cost of Revenue | N/A | N/A | $181-91.3% | $292 | $722 | $678 | $2K | N/A |
| Gross Profit | N/A | N/A | $238n/m | $448 | $865 | $791 | -$2K | N/A |
| R&D Expenses | N/A | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $26K+22.8% | $89K+193.6% | N/A | $1000K+540.6% | $21K | $30K | $26K | $156K |
| Operating Income | -$639Kn/m | -$1.7Mn/m | -$3.7Mn/m | -$999Kn/m | -$660K | -$539K | -$873K | -$156K |
| EBITDA | N/A | N/A | N/A | N/A | -$585K | -$464K | -$723K | N/A |
| Interest Expense | $39 | $287K+67110.5% | N/A | $19K+28695.5% | N/A | $427 | -$10K | $67 |
| Income Tax | N/A | $0n/m | N/A | N/A | N/A | $0 | N/A | N/A |
| Net Income | -$639Kn/m | -$2.0Mn/m | -$4.1Mn/m | -$1.0Mn/m | -$661K | -$539K | -$863K | -$156K |
| EPS (Basic) | -$0.10 | -$0.27 | -$0.29n/m | -$0.08 | -$0.05 | -$0.04 | -$0.07 | N/A |
| EPS (Diluted) | -$0.10 | -$0.27 | -$0.29n/m | -$0.08 | -$0.05 | -$0.04 | -$0.07 | N/A |
| Diluted Shares (Avg) | 9M | 14M | N/A | 13M | 13M | 13M | 13M | N/A |
CABR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'26S-1 | Q1'26S-1 | Q4'25S-1 | Q3'2510-Q | Q2'25S-1 | Q1'2510-Q | Q4'24S-1 | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9M | $2.2M | $2.3M-40.0% | $3.2M | N/A | N/A | $3.9M | N/A |
| Current Assets | $1.9M | $2.2M | $2.3M+341.1% | $46K | N/A | N/A | $527K | N/A |
| Cash & Equivalents | $1.8M | $2.0M | $2.2M+366.8% | $16K | N/A | N/A | $469K | N/A |
| Short-Term Investments | $0 | $0 | $0n/m | $0 | N/A | N/A | $0 | N/A |
| Inventory | $13K | $13K | $13K-6.4% | $13K | N/A | N/A | $14K | N/A |
| Long-Term Investments | $0 | $0 | $0n/m | $0 | N/A | N/A | $0 | N/A |
| Total Liabilities | $4.6M | $4.2M | $235K+26.5% | $572K | N/A | N/A | $186K | N/A |
| Current Liabilities | $385K | $384K | $177K-5.0% | $570K | N/A | N/A | $186K | N/A |
| Non-Current Liabilities | $4.2M | $3.8M | $59Kn/m | $2K | N/A | N/A | $0 | N/A |
| Long-Term Debt | N/A | N/A | $59K | $2K | N/A | N/A | N/A | N/A |
| Total Equity | -$2.7M-187.2% | -$2.0M-159.3% | $2.1M-43.3% | $2.6M-37.0% | $3.1M | $3.4M | $3.7M | $4.1M |
| Retained Earnings | -$9.8M | -$9.1M | -$7.1Mn/m | -$3.1M | N/A | N/A | -$863K | N/A |
Not reported in any period shown, so not listed: Accounts Receivable, Goodwill.
CABR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'26S-1 | Q1'26S-1 | Q4'25S-1 | Q3'2510-Q | Q2'25S-1 | Q1'2510-Q | Q4'24S-1 | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$463Kn/m | -$551Kn/m | -$1.1Mn/m | -$181K | -$209K | -$242K | -$272K | N/A |
| Depreciation & Amortization | N/A | N/A | N/A | N/A | $75K | $75K | $150K | N/A |
| Stock-Based Compensation | N/A | $969K | N/A | N/A | N/A | N/A | $400K | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | $609K | N/A |
| Financing Cash Flow | $250K | $395K | $3.2M | $123K | N/A | N/A | N/A | N/A |
| Share Buybacks | $0 | $3.1M | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid.
CABR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'26S-1 | Q1'26S-1 | Q4'25S-1 | Q3'2510-Q | Q2'25S-1 | Q1'2510-Q | Q4'24S-1 | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | 56.8% | 60.5% | 54.5% | 53.8% | -345.6% | N/A |
| Operating Margin | N/A | N/A | -891795.7% | -135064.2% | -41561.6% | -36715.0% | -187703.4% | N/A |
| Net Margin | N/A | N/A | -968990.5% | -137671.4% | -41624.6% | -36676.0% | -185546.5% | N/A |
| Return on Equity | N/A | N/A | -194.1%-170.8pp | -39.2%-35.4pp | -21.3% | -16.0% | -23.4% | -3.8% |
| Return on Assets | -33.5% | -92.5% | -174.5%-152.2pp | -32.1% | N/A | N/A | -22.3% | N/A |
| Current Ratio | 4.96 | 5.65 | 13.16+10.3x | 0.08 | N/A | N/A | 2.83 | N/A |
| Debt-to-Equity | N/A | N/A | 0.03 | 0.00 | N/A | N/A | N/A | N/A |
| Liabilities-to-Equity | N/A | N/A | 0.11+0.1x | 0.22 | N/A | N/A | 0.05 | N/A |
| Asset Turnover | N/A | N/A | 0.000.0x | 0.00 | N/A | N/A | 0.00 | N/A |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Caring Brands, Inc. CABR | FY2025 | $4K | -$6.3M | N/A | $9.4M | — |
| InMed Pharmaceuticals Inc. INM | FY2026 | N/A | -$12.6M | N/A | $9.6M | — |
| Universe Pharmaceuticals Inc. UPC | FY2025 | $17.9M | -$3.7M | -20.6% | $7.4M | 48/100 |
| Biofrontera Inc. BFRI | FY2025 | $41.7M | -$10.5M | -25.3% | $13.4M | 44/100 |
| Sonoma Pharmaceuticals, Inc. SNOA | FY2026 | $19.5M | -$3.2M | -16.3% | $5.3M | 37/100 |
| Gelteq Limited GELS | FY2025 | $109K | -$4.4M | N/A | $4.9M | — |
Where Caring Brands, Inc. Ranks
Frequently Asked Questions
Caring Brands, Inc. (CABR) reported $4K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
No, Caring Brands, Inc. (CABR) reported a net loss of $6.3M in fiscal year 2025.
Caring Brands, Inc. (CABR) had EBITDA of -$5.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Caring Brands, Inc. (CABR) had $2.2M in cash and equivalents against $59K in long-term debt.
Caring Brands, Inc. (CABR) had a gross margin of 55.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Caring Brands, Inc. (CABR) has a return on equity of -300.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Caring Brands, Inc. (CABR) recorded an outflow of $1.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Caring Brands, Inc. (CABR) had $2.3M in total assets as of fiscal year 2025, including both current and long-term assets.
Caring Brands, Inc. (CABR) had a current ratio of 13.16 as of fiscal year 2025, which is generally considered healthy.
Caring Brands, Inc. (CABR) had a debt-to-equity ratio of 0.03 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Caring Brands, Inc. (CABR) had a liabilities-to-equity ratio of 0.11 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Caring Brands, Inc. (CABR) had a return on assets of -269.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Caring Brands, Inc. (CABR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $9.4M as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Caring Brands, Inc. (CABR) has no price-to-sales ratio at the moment: outside the range published as a multiple (on $4K revenue, FY2025). The market capitalization is $9.4M as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, Caring Brands, Inc. (CABR) held $2.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $1.7M over that year. Dividing the one by the other, the reported balance equals about 16 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Caring Brands, Inc. (CABR) has an Altman Z-Score of 12.40, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Caring Brands, Inc. (CABR) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Caring Brands, Inc. (CABR) reported a net loss of $6.3M while operations used $1.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Caring Brands, Inc. (CABR) reported an operating loss of $5.9M against $19K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.